Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @JoshuaHillMD
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @JoshuaHillMD
-
Joshua Hill, MD proslijedio/la je Tweet
Our statement on why community vaccine rates are so important to cancer & transplant patients
@JAMAOnc Led by@UWMedicine MS-3@maresacw & co-authored with my Pediatric colleague Dr. Paul Carpenter@fredhutch@seattlechildren@SeattleCCA#VaccinesWork https://jamanetwork.com/journals/jamaoncology/fullarticle/2757399 …pic.twitter.com/aVRsLiMjol
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
Incredibly excited to share this work. Microbial cell-free DNA sequencing predicted bloodstream infection pathogens up to 3 days before onset of infection in immunocompromised children!!!https://jamanetwork.com/journals/jamaoncology/article-abstract/2757390 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
IDS 2020 Summer Internship applications now open!
8-10 wk early stage mentorship to promote understanding of infectious diseases & commitment to detection, prevention & treatment of infectious diseases in the immunocompromised host 
Pls RT!
https://form.jotform.com/fredhutch/IDS pic.twitter.com/TdyA8i0R3b
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
Patients whose cancers come back after CAR T cells are in a desperate situation w/few options. One possible strategy is a 2nd infusion of the same product. New data at
#ASH19 show that this seems to help some pts, & IDs variables linked to better odds.https://www.fredhutch.org/en/news/center-news/2019/12/repeat-dose-car-t-cells.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
Awareness is needed for
#TxID MDs/PharmDs about this drug-drug interaction - impt work by Arianne Duong &@SeattleCCA |@UWMedicine pharmacy teams (led by Dr Liu from@HutchIDScience) Clinically significant drug interaction: letermovir and voriconazolehttps://academic.oup.com/jac/advance-article-abstract/doi/10.1093/jac/dkz499/5652247#.XegqVhjRDbs.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
Glad you like it! At least in 2019, we aren’t embarking on this blind: we know how molds infect heme-onc patients because of the DECADES of clinical & research experience we have to draw from. How do we apply these concepts to CART? Molds are still devastating
@JoshuaHillMDhttps://twitter.com/ClancyNeil/status/1198238071055097856 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
CMV detection by quantitative PCR in fresh gastrointestinal (GI) mucosa is as useful as immunohistochemistry (IHC). PCR has the same sensitivity, specificity & predictive values as IHC. Quantitative PCR in gut is more reliable than IHC for CMV GI diseasehttps://www.bbmt.org/article/S1083-8791(19)30448-3/fulltext …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How does CD19 CAR-T cell therapy affect antiviral humoral immunity? Check out our new study here: https://bit.ly/2Xz6Z6h IVIG may not be routinely indicated but more work to be done to guide best clinical practice.pic.twitter.com/x0whF1ewSu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
Can we increase surface BCMA and augment anti-tumor efficacy of BCMA CAR T cells in MM with a gamma secretase inhibitor? Look forward to presenting our data at
#ASH19!@fredhutch@mwmcelroy@SeattleCCA https://ash.confex.com/ash/2019/webprogram/Paper129405.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
Check out the article highlighting our recent collaborative work with
@StamatatosL and@McGuire_Lab using anti-idiotypes.https://www.fredhutch.org/en/news/center-news/2019/10/hiv-vaccine-immunity-bnab.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
Measles vaccine
deaths by more than would be expected by reduction in measles cases alone. Could the broad immunosuppressive effects of this infection be the reason? Incredibly important study by @michaelmina_lab, just published in@sciencemagazine https://science.sciencemag.org/content/366/6465/599 …https://twitter.com/BrighamWomens/status/1189989502221266944 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
Fantastic work from
@HannahImlay from@UofUHealth during here time@HutchIDScience assessing abx allergies in HCT and SOT patients -
message is
number of beta lactam allergies reported & opportunities 4 evaluation pre-Tx -
mentor Dr. Liu @fredhutch https://bit.ly/2VOJOUQ pic.twitter.com/96bAh9MsNA
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
Incidence, Risk Factors &Outcomes of Idiopathic Pneumonia Syndrome (IPS) after Allo HSCT. The incidence of IPS is declining in a modern cohort of allogeneic-HCT recipients. TBI dose remains a significant risk factor for IPS development.https://www.bbmt.org/article/S1083-8791(19)30654-8/fulltext …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
NEW
in OFID @BradCutrellMD#WhyID: Crowdsourcing the Top Reasons to Choose Infectious Diseases in the Age of Twitter.#IDTwitter#medtwitter https://academic.oup.com/ofid/article/6/10/ofz403/5584298#.XZ33znOyCCo.twitter …pic.twitter.com/2hMbSi2oXL
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
Important new paper presented as abstract at
#IDWeek2019 that is just today in@BloodAdvances by@golob from@umichmedicine & colleagues from@fredhutch http://www.bloodadvances.org/content/3/19/2866?sso-checked=true …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
Question is butyrate producing bacteria and
#GVHD always good? Provocative data#microbiome@golobPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
This great graphic shows the profound positive impact of vaccines on human health
#WhyIVaccinate#IDWeek2019https://twitter.com/minouye271/status/1175890007875346432 …
1:29Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
@HutchIDScience virus expert Dr. Michael Boeckh will deliver the prestigious John F. Enders Lecture Oct. 5 at @IDWeek2019, an annual conference of doctors and researchers specializing in#infectiousdisease.#IDWeek2019@IDSAInfohttps://bit.ly/2oEOUq4Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joshua Hill, MD proslijedio/la je Tweet
Addressing gender bias in medicine! There is more work ahead so let’s keep pushing for change to make board certification as equitable as possible. https://www.journalofhospitalmedicine.com/jhospmed/article/208810/hospital-medicine/collective-action-and-effective-dialogue-address-gender ….
@JHospMedicine@PhysicianMomsGp#eliminatethestartdateHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Callitout Proud to support my wife@artidesai and colleagues in their work addressing#genderbias in medicine.#WomenInSTEM https://bit.ly/2mLFOYg pic.twitter.com/LH5La7AsMj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

Another big h/t to u/rarohde